skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Could you please comment on $CRH for a medium term hold, thanks Valter
Read Answer Asked by Valter on December 29, 2015
Q: Seasons Greetings!!!
Your last comment on Horizon Pharma was Feb/15. Could I have your current opinion please?
Thanks
Dave
Read Answer Asked by Dave on December 24, 2015
Q: The latest update on NHC delay in filing their financial statements seems to include a new issues of concern including accounting for warrants and option issued in the past, compensation matters and even calculations of fully diluted shares. A month after missing their filing date, there doesn't seem to be much progress and instead a number of new issues. Do you think the red flags are waving?
Read Answer Asked by Kent on December 24, 2015
Q: My question pertains to the loan Gud made to Extenway in June 2015. After looking at the Extenway financials I am perplexed to find a reason why GUD management would have entered into such an agreement in the first place. If their loan portfolio is anywhere close to this transaction I think there is a serious problem. Could I get your thoughts on this one.
Read Answer Asked by roland on December 22, 2015
Q: Now that they have started phase 1 trials with md Anderson, do you have any change to your view on the company??
Read Answer Asked by Bill on December 21, 2015
Q: Do you think the latest news in their drug approval is any reason to start a small speculative position.
Thanks
Read Answer Asked by David on December 18, 2015
Q: Hi guys,

Any news why Ten Peaks Coffee is hitting an all-time high on a 9% move? All I could find was a dividend announcement which would hardly be a catalyst for such a move.
Read Answer Asked by Edward on December 17, 2015
Q: Today, Acasti (APO) announced positive feedback from the US FDA and, as a result, its shares jumped about 50%. However, the share price of NTP, which owns almost 50% of APO, rose less than 10%. I would have expected an approx. 25% increase for NTP. Is this a good arbitrage opportunity?
Read Answer Asked by Gregory on December 17, 2015
Q: At this time, the only healthcare stock I hold is a 3% weighting in CXR. I would like to add to this sector. My question is, after today's developments with Valeant, would you recommend initiating a small position? Any other suggestions are most welcome.

Thank you
Read Answer Asked by Rose on December 16, 2015
Q: This sector is incredibly exciting. What's your take on medical devices please. Thanks.
Read Answer Asked by Norman on December 14, 2015
Q: As this is likely my last missive this year; I wish you all at 5i the best for this Holiday Season and may you all prosper in 2016. What are your views on CXV? Many thanks again. Henry
Read Answer Asked by Henry on December 11, 2015
Q: What do you think about MSL for a 10 year hold? I have a small position and I'm wondering if its worth holding long term. Thanks, Neil
Read Answer Asked by Neil on December 08, 2015
Q: Your take on latest numbers reported and where this company is headed.Thank You
garry
Read Answer Asked by garry on December 08, 2015
Q: My healthcare exposure is very lean with CVS as my only current holding. What names interest you that would warrant further research on my part? It will likely be held in a TFSA. I'm looking for a moderate growth/risk name at this time.
Thanks!
Read Answer Asked by Jeffrey on December 08, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!